Skip to main content
. 2024 Mar 29;8:81. doi: 10.1038/s41698-024-00572-3

Table 1.

Patient characteristics and disease history

Disease characteristics at diagnosis Metastatic disease history and unexpected post-mortem findings
Patient Age (years) Race Type Subtype Stage TNM Primary to metastatic Dx (months) Metastatic Dx to death (months) Primary Dx to death (months) Clinically Diagnosed Metastatic Organ Involvement Undiagnosed Findings Post-mortem Micrometastases Identified by IF
1 46 Asian IDC Low HR / TNBC IIA T1N1a 19 10 29 L breast, Skin, Shoulder musculature, Chest wall, L Lung N/A N/A
2 31 Caucasian IDC HR+ IIA T2N0 16 31 47 R breast, Lungs, Liver, Adrenals, Bone, Brain Anterior Chest Mass, Spleen, Ovaries, Dura Pancreas
3 32 Caucasian IDC HR+ IIIB T3N1a 54 86 140 L breast, Anterior chest mass, Thyroid, Lungs, Liver, Bone Pancreas, Adrenals N/A
4 47 Middle Eastern IDC HR+ IIB T2 N1a 125 163 284 L breast, Chest wall, Liver, Bone, Brain R Lung, Adrenal Non-tumor-draining lymph nodes
5 37 Caucasian IDC TNBC III/IV T4dN1 1 12 13 L breast, Skin, Bone R Breast Non-tumor-draining lymph nodes
6 67 Caucasian IDC Low HR /TNBC II T2N0 30 30 60 L Breast, Anterior Chest Mass, Chest wall, Lungs, Abdominal mass, Bone, Brain Liver N/A
7 58 Caucasian Lobular HR+ IV N/A* De novo metastatic 35 35 R breast, GI, Bone, Brain, Lung N/A N/A
8 69 Caucasian IDC HR+ I T3mN0 27 7 34 L + R breast, Skin, R Lung, Liver, Brain L Lung, R Adrenal, Kidneys N/A
69 IDC TNBC IIa cT2cN0
9 53 Asian IDC Low HR /TNBC IIIC cT2-3N3 7 6 13 R breast, Liver, Bone, Skin L Breast, R Chest Wall, L Lung, Adrenals** Spleen, Bone, Non-tumor-draining lymph nodes

*De novo metastatic with occult primary ** Not diagnosed but identified on imaging retrospectively; IDC invasive ductal carcinoma, TNBC triple-negative breast cancer, HR hormone receptor, TNM tumor, node, metastasis, L left, R right, GI gastro-intestinal.